| Horace Liang, MD | |
|
600 N Wolfe St, Baltimore, MD 21287-0005 | |
| (410) 955-2280 | |
| Not Available |
| Full Name | Horace Liang |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 600 N Wolfe St, Baltimore, Maryland |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255372553 | NPI | - | NPPES |
| 482491100 | Medicaid | MD |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | D35468 (Maryland) | Primary |
| Entity Name | Global Physician Network Llc Series I |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1316467525 PECOS PAC ID: 7214202365 Enrollment ID: O20170929000797 |
News Archive
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
New research from Britain suggests that when the elderly are treated for hypertension (high blood pressure) the medication reduces their risk of heart disease, stroke and even death.
This study demonstrates that exercise training, including resistance exercise training, is a feasible, low-risk treatment that can potentially reduce worry symptoms among generalized anxiety disorder (GAD) patients and may be an effective adjuvant, short-term treatment or augmentation for GAD.
The rarity of appendix cancer, accounting for less than 1 percent of tumors that originate in the gastrointestinal tract, and the lack of scientific data for this disease means that current treatment guidelines recommend applying therapies to people with appendix cancer that are intended for those with colon cancer.
Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Jakafi (ruxolitinib) for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Horace Liang, MD Po Box 64362, Baltimore, MD 21264-4362 Ph: () - | Horace Liang, MD 600 N Wolfe St, Baltimore, MD 21287-0005 Ph: (410) 955-2280 |
News Archive
Genaera Corporation has announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to squalamine, an intravenously administered, first in class, small molecule anti-angiogenic drug for the treatment of "wet" age-related macular degeneration (AMD).
New research from Britain suggests that when the elderly are treated for hypertension (high blood pressure) the medication reduces their risk of heart disease, stroke and even death.
This study demonstrates that exercise training, including resistance exercise training, is a feasible, low-risk treatment that can potentially reduce worry symptoms among generalized anxiety disorder (GAD) patients and may be an effective adjuvant, short-term treatment or augmentation for GAD.
The rarity of appendix cancer, accounting for less than 1 percent of tumors that originate in the gastrointestinal tract, and the lack of scientific data for this disease means that current treatment guidelines recommend applying therapies to people with appendix cancer that are intended for those with colon cancer.
Incyte Corporation today announced that the U.S. Food and Drug Administration (FDA) has granted marketing approval for Jakafi (ruxolitinib) for the treatment of patients with intermediate or high-risk myelofibrosis (MF), including primary MF, post-polycythemia vera MF and post-essential thrombocythemia MF.
› Verified 5 days ago
Ankita Taneja, MD, MPH Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-2079 | |
Scott Mcpherson, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 301 Saint Paul Pl, Baltimore, MD 21202 Phone: 410-332-9809 | |
Larry Weiss, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 22 S Greene St, Baltimore, MD 21201 Phone: 410-328-4383 | |
Shannon Brandy Putman, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-2280 | |
Arjun S Chanmugam, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 600 N Wolfe St, Baltimore, MD 21287 Phone: 410-955-2280 | |
Dr. Donald W Alves, MD, MS, FACEP Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1201 Reisterstown Road, Medical Services, Baltimore, MD 21208 Phone: 410-653-8366 Fax: 410-653-4290 | |
Michael Rayner Leedom, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 22 S Greene St, Emergency Dept, Baltimore, MD 21201 Phone: 410-328-8025 Fax: 410-328-8028 |